Analytical Data
-
Gene name
GPBP1
- Application
-
Alternative Names
GC-rich promoter-binding protein 1Vascular wall-linked protein
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86WP2
-
Expression Region
293-473aa
-
Molecular Weight
36.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPBP1 (Guanine-rich Binding Protein 1) is a multifunctional protein that has garnered significant attention in recent years due to its involvement in various cellular processes, including gene regulation, DNA binding, and cellular signaling. Research has shown that GPBP1 plays a crucial role in the transcription of genes associated with stress responses and immune functions, highlighting its potential significance in disease states, such as cancer and neurodegenerative disorders. The study of recombinant GPBP1 protein offers insights into its structural and functional properties, aiding in understanding its mechanisms of action at the molecular level. Advances in protein engineering have facilitated the production of GPBP1 in a recombinant form, enabling detailed biochemical and biophysical characterization. Such investigations are vital for elucidating the role of GPBP1 in cellular pathways and may pave the way for targeted therapeutic strategies. As GPBP1 can influence several key pathways, including those mediated by nucleic acids, it stands as a promising candidate for further exploration in drug development and biomarker identification. The continued study of GPBP1 and its recombinant forms aims to unravel its complex biology and therapeutic potential, making it a significant focus in molecular and cellular research.
